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Abstract
Background: Identifying developmental processes regulated by Notch1 can be addressed in part by characterizing 
mice with graded levels of Notch1 signaling strength. Here we examine development in embryos expressing various 
combinations of Notch1 mutant alleles. Mice homozygous for the hypomorphic Notch112f allele, which removes the 
single O-fucose glycan in epidermal growth factor-like repeat 12 (EGF12) of the Notch1 ligand binding domain (lbd), 
exhibit reduced growth after weaning and defective T cell development. Mice homozygous for the inactive Notch1lbd 
allele express Notch1 missing an ~20 kDa internal segment including the canonical Notch1 ligand binding domain, 
and die at embryonic day ~E9.5. The embryonic and vascular phenotypes of compound heterozygous Notch112f/lbd 
embryos were compared with Notch1+/12f, Notch112f/12f, and Notch1lbd/lbd embryos. Embryonic stem (ES) cells derived 
from these embryos were also examined in Notch signaling assays. While Notch1 signaling was stronger in Notch112f/lbd 
compound heterozygotes compared to Notch1lbd/lbd embryos and ES cells, Notch1 signaling was even stronger in 
embryos carrying Notch112f and a null Notch1 allele.
Results: Mouse embryos expressing the hypomorphic Notch112f allele, in combination with the inactive Notch1lbd allele 
which lacks the Notch1 ligand binding domain, died at ~E11.5-12.5. Notch112f/lbd ES cells signaled less well than 
Notch112f/12f ES cells but more strongly than Notch1lbd/lbd ES cells. However, vascular defects in Notch112f/lbd yolk sac were 
severe and similar to Notch1lbd/lbd yolk sac. By contrast, vascular disorganization was milder in Notch112f/lbd compared to 
Notch1lbd/lbd embryos. The expression of Notch1 target genes was low in Notch112f/lbd yolk sac and embryo head, 
whereas Vegf and Vegfr2 transcripts were increased. The severity of the compound heterozygous Notch112f/lbd yolk sac 
phenotype suggested that the allelic products may functionally interact. By contrast, compound heterozygotes with 
Notch112f in combination with a Notch1 null allele (Notch1tm1Con) were capable of surviving to birth.
Conclusions: Notch1 signaling in Notch112f/lbd compound heterozygous embryos is more defective than in compound 
heterozygotes expressing a hypomorphic Notch112f allele and a Notch1 null allele. The data suggest that the gene 
products Notch1lbd and Notch112f interact to reduce the activity of Notch112f.
Background
Notch transmembrane receptors are important regula-
tors of cell fate determination in numerous cell types [1-
3]. Notch receptors in Drosophila and mammals are
covalently modified with O-fucose on many epidermal
growth factor-like (EGF) repeats of the extracellular
domain [4]. An important O-fucose site resides in epider-
mal growth factor-like repeat 12 (EGF12) which, together
with EGF11, is required for canonical Notch ligand bind-
ing to Drosophila Notch [5-7] and to mammalian Notch1
[8]. A point mutation that precludes the addition of
fucose to EGF12 in Drosophila Notch results in enhanced
binding of both Delta and Serrate Notch ligands, and a
hyperactive Notch that is refractory to Fringe [9]. How-
ever, the same mutation (Notch112f) in cultured mamma-
lian cells gives markedly reduced signaling in a Notch
reporter signaling assay [10,11], predicting a Notch1 null
phenotype  in vivo. Surprisingly however, homozygous
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Notch112f/12f  mice are viable and fertile, but exhibit
retarded growth and mild defects in T cell development
in the thymus [12], consistent with weak Notch1 signal-
ing. Notch1+/12f heterozygotes are indistinguishable from
wild type in terms of growth and T cell development.
However, compound heterozygotes carrying Notch112f
and the inactive Notch1lbd allele, which lacks the ligand
binding domain and generates an inactive ~280 kDa
Notch1 receptor at the cell surface, are not born [12].
Therefore Notch112f is a hypomorphic allele in mammals
and the O-fucose glycan in the ligand binding domain is
required for optimal Notch1 signaling. Homozygous
Notch1lbd/lbd embryos die at ~E9.5 [8,12] with an indistin-
guishable phenotype compared to Notch1 null embryos
(Notch1in32/in32 and Notch1tm1Con/tm1Con) described by oth-
ers [13,14]. Heterozygous Notch1+/lbd and Notch1+/tm1Con
mice are viable and fertile whereas Notch112f/lbd  com-
pound heterozygotes die between E11.5 and E12.5, signif-
icantly later than either Notch1lbd/lbd [12] or Notch1 null
embryos [13,14] that do not express Notch1 [15-17].
The availability of these Notch1  mutant alleles sug-
gested a genetic approach to determining effects of vary-
ing Notch1 signaling strength. The Notch1lbd mutation
generates a non-functional but cell surface-expressed
Notch1 that cannot signal [8,12]. Notch1tm1Con  lacks
Notch1 on the cell surface due to the absence of its trans-
membrane domain [14]. Notch1in32 homozygous embryos
have no Notch1 transcripts [13] and an indistinguishable
phenotype from Notch1tm1Con homozygotes which lack
Notch1 based on western analyses [15,18]. Notch1+/-
heterozygotes carrying either of the Notch1  null alleles
exhibit Notch1 signaling defects in certain cell types, an
effect attributed to Notch1 haploinsufficiency rather than
to a dominant negative effect in Notch1tm1Con [18-21]. In
this paper we compare embryogenesis and vasculogene-
sis in compound heterozygotes expressing the hypomor-
phic  Notch112f allele with either the inactive Notch1lbd
allele [8,12] or the Notch1tm1Con null allele [14].
Results
Notch signaling in Notch112f/lbd compound heterozygous 
ES cells
The  Notch112f and Notchlbd alleles investigated here are
diagrammed in Fig. 1A and 1B and their identification by
PCR genotyping is shown in Fig. 1C. Previous studies
showed that Notch112f/lbd compound heterozygotes die by
~E12.5 [12]. To examine Notch ligand binding and the
strength of Notch signaling in more detail, ES cells were
derived from Notch112f/lbd compound heterozygous blas-
tocysts and compared to ES cells derived from Notch112f/
12f  and  Notch1lbd/lbd  homozygous blastocysts and wild
type ES cells (Fig. 2). All cell lines bound the anti-Notch1
extracellular domain mAb 8G10 equivalently, and there-
fore expressed the various Notch1 molecules similarly at
the cell surface (Fig. 2A). Each mutant line exhibited a
decrease in the low level of soluble Delta1 binding
o b s e rv e d  w i t h  w i l d  t y p e  E S  c e l l s  ( F i g.  2 B ) .  B i n d i n g  o f
Delta1 is not reduced to zero even in Notch1 null ES cells
because of the presence of Notch2, Notch3 and Notch4
[17]. Notch signaling was analysed in co-culture assays
with L cells or L cells expressing full length Delta1 or
Jagged1 ligand. This reporter assay revealed a graded
reduction in Notch signaling with Notch112f/12f
>Notch112f/lbd  >Notch1lbd/lbd  ES cells (Fig. 2C-D). This
graded response was also observed by western analysis
using Notch1 antibody Val1744 [15] which detects the
~110 kDa Notch1 fragment generated by γ-secretase
complex cleavage of Notch1. The level of activated
Notch1 in Notch112f/lbd ES cells was less than in Notch112f/
12f ES cells, which was lower than in control ES cells, while
Notch1lbd/lbd ES cells had undetectable levels of activated
Notch1 (Fig. 2E). Nevertheless, all ES cell populations,
including Notch1lbd/lbd ES cells, expressed equivalent lev-
els of full-length Notch1 (Fig. 2E). Taken together, these
data indicate that Notch112f and Notch1lbd expression and
transit to the cell surface were similar to wild type
Notch1, but Notch1 signaling was reduced in mutant
cells: Notch112f signaling was sightly less than wild type;
Figure 1 Generation of Notch112f/lbd embryos. (A) Diagram of the 
Notch112f and Notch1lbd alleles. (B) Diagram of mouse Notch1 EGF re-
peats in Notch112f and Notch1lbd extracellular domains. The EGF re-
peats with putative O-fucosylation sites are shaded in gray and the 
mutation in EGF12 is shown. (C) Genotyping by PCR from E9.5 yolk sac 
DNA of a litter from a Notch112f/12f × Notch1+/lbd cross. Primers 5F and 6R 
detect the Notch112f and Notch1+ alleles, primers 5F and 9R detect the 
Notch1lbd allele.Ge and Stanley BMC Developmental Biology 2010, 10:36
http://www.biomedcentral.com/1471-213X/10/36
Page 3 of 13
signaling from the combination of Notch112f  and
Notch1lbd  was further reduced, and signaling by
Notch1lbd alone was essentially absent. Previous experi-
ments have shown that Notch1lbd/lbd and Notch1in32/in32 ES
cells which lack Notch1 [13,15,16], are equally deficient
in Delta1-Fc binding and Notch1 signaling [12].
Embryogenesis in Notch112f/lbd compound heterozygous 
embryos
Embryonic development was compared between
Notch112f/12f,  Notch112f/lbd and  Notch1lbd/lbd embryos. At
E9.5  Notch112f/lbd embryos formed 17-21 somites com-
pared to 23-26 somites in Notch112f/12f embryos, the same
Figure 2 A graded reduction in Notch1 signaling in Notch112f/lbd ES cells. (A) Notch1 expression on the surface of ES cells (Notch1+/+, Notch112f/
12f, Notch112f/lbd and Notch1lbd/lbd) was analyzed by flow cytometry using anti-Notch1 mAb 8G10 (solid line). Shaded profiles are secondary Ab only. (B) 
Delta1-Fc binding to ES cells. Control is secondary antibody alone. 5 mM EDTA inhibited ligand binding to control levels (gray). Data are mean ± SEM 
(n = 4), * p < 0.05 between Notch1+/+ and all mutant lines. (C) Delta1-induced Notch signaling and (D) Jagged1-induced Notch1 signaling were deter-
mined by co-culturing ES cells with Delta1/L or Jagged1/L cells compared to control L cells after transfection of a Notch reporter construct. Bars rep-
resent fold-activation ± SEM (n = 4), * p < 0.05; ** p < 0.01, *** p < 0.001 based on the two-tailed Student's t test; (E) Whole cell lysates from ES cells 
were subjected to western analysis using the Val1744 antibody for activated Notch1 and the 8G10 antibody for full length Notch1. The histogram 
shows the relative expression of activated Notch1 after normalization to β-tubulin III (mean ± SEM from 4 experiments).Ge and Stanley BMC Developmental Biology 2010, 10:36
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as Notch1+/+ embryos, and 13-17 somites in Notch1lbd/lbd
embryos [8], the same as Notch1tm1Con null embryos [14]
(Table 1). Compared to Notch112f/12f  and  Notch1+/12f
embryos,  Notch112f/lbd  embryos also showed severely
defective vasculogenesis in yolk sac at E9.5, similar to
Notch1lbd/lbd yolk sac. By contrast, Notch112f/lbd embryos
at E9.5 and E10.5 exhibited milder defects in develop-
ment than Notch1lbd/lbd embryos [12] (Fig. 3), although
the ballooning of the pericardial sac and defective heart
development were severe, and similar to mutants globally
defective in Notch signaling such as mutants lacking
Pofut1 [22], RBPJk [23] or presenilins 1 and 2 [24]. Taken
together, these data indicate that two copies of Notch112f
do not noticeably affect mouse embryogenesis at a gross
level, whereas a single copy of Notch112f with Notch1lbd
support embryonic development ~2.0-2.5 days longer
than embryos with two copies of Notch1lbd.
Vasculogenesis in yolk sac appears to require stronger 
Notch1 signaling than in the embryo
Notch1 signaling is critical for vasculogenesis during
mouse embryogenesis [25]. Loss of Notch1 in embryos
[26] or in endothelial cells [27] causes embryonic lethality
with severe vascularization defects in yolk sac, placenta
and embryo. Blood that had leaked from the heart and
blood vessels was apparent in Notch112f/lbd embryos (Fig.
3I-K; arrows). Vascular organization in embryos was
examined by staining with anti-Pecam1 (endothelial
marker platelet/endothelial cell adhesion molecule-1).
Notch112f/12f embryos (Fig. 4B, F, J, N) did not exhibit any
apparent defects in brain, heart or intersomitic vascular-
ization compared to Notch1+/12f  embryos.  Notch112f/lbd
embryos exhibited somewhat disorganized vasculariza-
tion in embryos, especially in the main trunk of the ante-
rior cardinal vein, the vascular network of the head and
heart, and in intersomitic vessels (Fig. 4C, G, K, O).
Notch1lbd/lbd embryos exhibited severe defects in vascu-
larization (Fig. 4D, H, L, P). Therefore, the extensive vas-
cularization in E9.5 and older Notch112f/lbd  embryos
appears to be well supported by the level of Notch1 sig-
naling provided by the Notch112f allele. Considering that
the vascular defects in yolk sac of compound heterozy-
gous Notch112f/lbd and homozygous Notch1lbd/lbd embryos
were similarly severe, the comparatively milder defects in
Notch112f/lbd  embryos indicated that Notch1 signaling
from a single copy of Notch112f, while not sufficient to
support vascularization in yolk sac at E9.5, is able to sup-
port a high level of vascularization in E9.5 embryos. It
seems that vascularization in yolk sac requires stronger
Notch1 signaling than in the embryo.
Notch1 target gene expression in E9.5 yolk sac versus 
embryo
Whereas vascularization was severly affected in both yolk
sac and embryo of Notch1lbd/lbd embryos, only the yolk sac
of Notch112f/lbd compound heterozygous embryos exhib-
ited extremely defective vascularization. To investigate
further, the expression of vasculogensis-related and
Notch1 target genes was examined by real-time PCR
using total RNA isolated from E10.5 Notch112f/lbd and
Notch1+/12f  yolk sacs and embryo heads. The relative
expression levels of Pecam1 and Vegf were increased in
Notch112f/lbd yolk sacs and embryos, and Vegfr2 expres-
sion was increased in Notch112f/lbd embryo heads (Fig. 5A-
C). Therefore loss of Notch1 signaling upregulated tran-
scription of the Pecam1, Vegf and Vegfr2 genes. Interest-
ingly, the increased expression of Vegf  and  Vegfr2  was
greater in Notch112f/lbd embryos, consistent with the rela-
tive strength of Notch1 signaling being greater in yolk
sac. Expression of the Notch1 target genes Hes5, Hey1
Table 1: Somite Numbers in Notch1 Mutants
Genotype Stage No. Embryos No. Somites
+/12f or +/+ E9.5 8 23,23,24,24,24,25,25,26
12f/12f E9.5 4 23,24,25,26
12f/lbd E9.5 6 17,17,18,18,19,21
12f/tm1Con E9.5 7 18,19,21,21,23,24,26
lbd/lbd E9.5 6 13,14,14,16,17,17,
tm1Con/tm1Con E9.5 * ≤ 14
+/12f or +/+ E10.5 3 33,34,35
12f/12f E10.5 3 32,32,34
12f/lbd E10.5 5 18,18,21,22,23
Somites were counted in embryos of Notch1+/+, Notch1+/12f, Notch112f/12f, Notch112f/lbd, Notch112f/tm1Con and Notch1lbd/lbd at E9.5. *Somite 
numbers in Notch1tm1Con/tm1Con embryos are from Conlon et al. [14].Ge and Stanley BMC Developmental Biology 2010, 10:36
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and Hey2 was reduced in Notch112f/lbd yolk sac (Fig. 5D-
F), but the level of Hes1 transcripts was not changed (data
not shown). In embryos, only the expression of Hes5 was
significantly reduced compared to control. The expres-
sion of Ang1, Tie2 and Ephrin-B2 which are involved in
angiogenesis, as well the expression of Notch1 itself, were
not changed in Notch112f/lbd yolk sac or embryos (data not
shown). The fact that the increase in Vegf  and  Vegfr2
transcripts was more in embryo head than yolk sac (418%
vs 170% for Vegf; 227% vs. 148% for Vegfr2; Fig. 5B and
6C), and the fact that the reduction in Notch target gene
expression was greater in yolk sac than embryo head, cor-
related generally with Notch1 signal strength and the
greater severity of vascularization defects in yolk sac ver-
sus embryo head.
Notch112f may function to birth in the absence of Notch1lbd
The severity of the Notch112f/lbd phenotype suggested an
interaction between Notch112f and Notch1lbd that inter-
fered with signaling by Notch112f. In this case, compound
heterozygous embryos expressing a Notch112f allele and a
Notch1 null allele might be expected to have a milder
Figure 3 Embryogenesis in Notch112f/lbd embryos. (A-D) Vascularization of yolk sac in Notch1+/12f, Notch112f/12f, Notch112f/lbd and Notchllbd/lbd embry-
os at E9.5. Large vitelline blood vessels were present in Notch1+/12f and Notch112f/12f yolk sacs, but absent in the Notch112f/lbd and Notch1lbd/lbd mutants. 
(E-H) Morphology of embryos at E9.5. Notch112f/12f are similiar to Notch1+/12f, Notch112f/lbd are markedly underdeveloped, and Notch1lbd/lbd are severely 
underdeveloped. (I-L) Notch112f/lbd embryos from E10.5-E12.5. White arrows show hemorrhaging in E10.5 and E11.5 embryos; most E12.5 embryos 
were resorbing. The number of embryos examined at each stage is given in Table 1.Ge and Stanley BMC Developmental Biology 2010, 10:36
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phenotype than Notch112f/lbd embryos. Notch112f/12f mice
were crossed with Notch1+/tm1Con  heterozygotes and
embryos were examined at E9.5 and later (Fig. 6, Table 2).
Some Notch112f/tm1Con embryos died between E11.5 and
E12.5 with similar defects to Notch112f/lbd embryos. How-
ever, this is ~1.5 days later than observed with
Notch1tm1Con/tm1Con  homozygous embryos who were
mostly dead by E10 [14]. However, nearly one third of the
Notch112f/tm1Con  embryos developed beyond E12.5 and
died at various times during embryogenesis, including
after birth (Table 2). Two Notch112f/tm1Con  pups were
found after birth, but none were observed after postnatal
day 7 (Fig. 6, Table 2). Somite numbers in Notch112f/tm1Con
embryos varied from as low as Notch112f/lbd embryos to as
h i g h  a s  w i l d  t y p e  e m b r y o s  ( T a b l e  1 ) .  T a k e n  t o g e t h e r ,
these results indicate that Notch112f receptors present at a
50% dose in vivo, generate stronger Notch1 signaling than
Notch112f in combination with Notch1lbd. This provides
genetic evidence that Notch112f and Notch1lbd may func-
tionally interact.
Discussion and Conclusions
In this paper we show that Notch1 signaling is greatly
reduced in Notch112f/lbd ES cells and compound heterozy-
gous embryos, but is significantly greater than in
Notch1lbd/lbd ES cells or homozygous embryos. The pres-
ence of the hypomorphic Notch112f allele allows vasculo-
genesis to proceed further and embryos to survive ~1.5-2
Figure 4 Defects in vascular remodeling in Notch112f/lbd E9.5 embryos. All whole mount embryos were stained with Ab to Pecam1. (A-D) Mor-
phogenesis of the main trunk of the anterior cardinal vein (arrow) in Notch112f/lbd and Notch1lbd/lbd mutant embryos is defective compared to Notch112f/
12f and control Notch1+/12f embryos. (E-H) Vascular remodeling in brain in Notch1+/12f and Notch112f/12f is similar but is defective in Notch112f/lbd and se-
verely defective in Notch1lbd/lbd embryos. (I-L) Vascular remodeling in heart is defective in Notch112f/lbd and more severely affected in Notch1lbd/lbd em-
bryos. (M-P) Intersomitic vessels (arrows) were well-organized in Notch1+/12f and Notch112f/12f embryos but were mildly disorganized in Notch112f/lbd and 
essentially absent from Notch1lbd/lbd embryos. The number of embryos examined was 3 - 4 of each genotype.Ge and Stanley BMC Developmental Biology 2010, 10:36
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days longer. The vascular system develops early during
mammalian embryogenesis. Initially, endothelial cell pre-
cursors differentiate and coalesce into a primitive net-
w o r k  o f  u n d i f f e r e n t i a t e d  b l o o d  v e s s e l s  ( t h e  p r i m a r y
vascular plexus) in both the mammalian embryo and its
extraembryonic membrane the yolk sac, in a process
termed vasculogenesis [28]. Subsequently, the primary
vascular plexus is remodeled into a highly organized and
functionally competent vascular network in a process
termed angiogenesis [29,30]. These processes are con-
trolled by several signaling molecules, including vascular
endothelial growth factor (VEGF) and its receptors [31],
angiopoeitin 1 and its receptor Tie2 [32], Ephrin-B
ligands and EphB receptors [33], TGFβ and its receptors
[34], and Notch receptors and their ligands Delta and Jag-
ged [25,26,35-38]. Defects in vasculogenesis are one of
the major reasons that Notch1 null embryos die at mid-
gestation [13,26]. Conditional mutation of Notch1 in vas-
cular endothelial cells using the Tie2-Cre  transgene
showed that embryos lacking endothelial cell Notch1 die
at ~E10.5 with profound vascular defects in placenta, yolk
sac, and the embryo proper [27]. The Notch1 target genes
Hey1 and Hey2 are also essential for embryonic vascular
development [39]. A requirement for Notch signaling in
the maintenance of vascular homestasis and the repres-
sion of endothelial cell proliferation is also indicated in
adult mice by conditional deletion of RBP-Jκ in endothe-
lial cells [40].
Interestingly,  Notch112f/lbd  embryos allowed us to
observe that vasculogenesis is regulated to different
extents in yolk sac and embryo by Notch1 signaling.
Thus, vascular defects in Notch112f/lbd yolk sac were as
severe as in Notch1lbd/lbd yolk sac, but vascular defects in
Notch112f/lbd embryo heads were comparatively mild. The
vasculogenic phenotype of Notch112f/lbd embryos was also
milder than reported for Jagged1 or Notch1 or Notch1/4
Figure 5 Real-time PCR of vasculogenic and Notch target genes in Notch112f/lbd yolk sac and embryo. Total RNA extracted from E10.5 yolk sac 
or embryonic head was reverse-transcibed and subjected to real-time PCR. Numbers of transcripts were normalized to β-actin, and the average rela-
tive expression of Notch1+/12f samples was set to 1. (A-F) Relative expression of Pecam1, Vegf, Vegfr2, Hes5, Hey1, and Hey2 as marked. Bars represent 
SEM (n = 6). The two-tailed Student's t test was used in control versus mutant yolk sac and embryo head comparisons; a one-tailed Student's t test 
was used in mutant yolk sac versus mutant embryo head comparisons; * p < 0.05; ** p < 0.01Ge and Stanley BMC Developmental Biology 2010, 10:36
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Figure 6 Notch112f/tm1Con embryos survive longer than Notch112f/lbd embryos. (A) PCR genotype of an E9.5 litter showed the 280 bp PCR product 
from Notch1tm1Con allele and the 238 bp product from the Notch112f allele. (B) Yolk sac vascularization of E10.5 Notch112f/tm1Con and Notch1+/12f embryos. 
(C) Notch112f/tm1Con embryos at E10.5 exhibit heamorrhaging around the heart (arrows). (D) Notch112f//tm1Con and control embryos at E15.5. One 
Notch112f/tm1Con embryo was defective but the other had no obvious defects. (E) Notch112f/tm1Con and control embryos at E17.5. One Notch112f/tm1Con 
embryo was defective but the other had no obvious defects. (F) Photo of a litter on postnatal day 1 (P1) which included one pup identified as Notch112f/
tm1Con by PCR genotyping below. The pup was indistingishable but died within a few days. (G) PCR genotype of the P1 litter in panel F.Ge and Stanley BMC Developmental Biology 2010, 10:36
http://www.biomedcentral.com/1471-213X/10/36
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null embryos [13,26,37], reflecting the presence of a low
level of Notch1 signaling in Notch112f/lbd  compound
heterozygotes. The reduced strength of Notch1 signaling
was responsible for defective artery development in
Delta-like 4 (Dll4) heterozygous embryos [38]. Hes5 and
Hey1 are Notch1 target genes, and Notch1 downregulates
expression of Hesr-1/Hey1 thereby enhancing expression
of its target gene Vegfr2 in endothial cells [41]. In addi-
tion, Vegf is upregulated six-fold in Hey1/2 double knock-
out embryos [39]. Notch1 has also been proposed to reg-
ulate vasculogenesis and angiogenesis via induction of
Ephrin-B2 [42,43] and Ang1 [44,45], and suppression of
Vegfr-2/Kdr  [41,46]. Consistent with this, we observed
enhanced suppression of Vegfr2 and Vegf in Notch112f/lbd
yolk sac and embryo. However, we observed no change in
the expression of Ang1, Tie2, Ephrin-B2 or Notch1 itself,
although experiments in human endothelial cells indicate
that Ang1 and Tie2 are Notch1 target genes [44,45]. Eph-
rin-B2 was reported to respond to Notch4, but not to
Notch1, through Delta-like 4 in differentiating HUVEC
cells [43], so it was perhaps not surprising that Ephrin-B2
expression was unchanged in Notch112f/lbd  yolk sac or
embryo. Thus, decreased Notch1 signaling may inhibit
vascular development in yolk sac more than in embryos
by inducing more Vegf and Vegfr2 through generating less
Hes5 and Hey1 mRNA in yolk sac.
The prolonged embryonic development supported by
the hypomorphic Notch112f allele was only ~1.5-2 days for
Notch112f/lbd embryos compared to Notch1lbd/lbd [8,12], or
Notch1  null embryos [13,14]. By contrast Notch112f/12f,
Notch1+/lbd or Notch1+/- heterozygotes are viable and fer-
tile [12-14,20]. This suggests that Notch1lbd may interfere
with Notch112f in a process termed negative complemen-
tation for Abruptex Notch mutants in Drosophila [47,48].
The basis of negative complementation is most com-
monly attributed to the products of the mutant alleles
interacting physically [47]. Thus Notch1lbd may either be
dominant negative and inhibit Notch112f activity, or may
not form a functional dimer or higher oligomer with
Notch112f, if that is required for Notch1 to function. We
prefer the latter hypothesis because there is no evidence
to date that Notch1lbd behaves as a dominant negative in
Notch1+/lbd heterozygotes [8,12]. Unfortunately, attempts
to prove the existence of dimers or higher oligomers of
Notch1 expressed at endogenous levels have so far been
unsuccessful and previous attempts came to opposite
conclusions. While two groups found that overexpressed
Notch1 transfected into cultured cells may form dimers
through the transmembrane domain or the extracellular
domain EGF repeats, one group concluded that dimeriza-
tion is necessary for Notch1 to signal [49], while the other
concluded that Notch1 signals without the need for
dimerization, and is present mainly as a monomer on the
cell surface [50]. Both studies characterized transiently-
transfected Notch1 expressed at much higher levels than
endogenous Notch1, which might induce anomolous
interactions.
If Notch1lbd reduces the effective amount of Notch112f
to a level insufficient to sustain development, we rea-
soned that Notch112f expressed in the context of a Notch1
Table 2: Notch112f/tm1Con pups may survive to birth
Stage 12f/12f × +/tm1Con 12f/12f × +/lbd
Litters Pups +/12f 12f/
tm1Con
Litters Pups +/12f 12f/lbd
E9.5 3 23 11 12 5 38 18 20
E10.5 3 23 13 10 8 70 37 33
E11.5 4 24 16 8 7 48 28 20
E12.5 5 25 21 4 8 33 28 5
E13.5 5 27 21 6 5 23 23 0
E 1 5 . 5 3 1 3 9 4 ----
E17.5 5 19 17 2 - - - -
P 162 5 2 32 - - - -
Wean 13 50 50 0 8 30 30 0
Embryos (E9.5 -- E17.5), post-natal pups (P1) and mice after weaning were genotyped from crosses of Notch112f/12f female × Notch1+/tm1Con male 
or crosses of Notch112f/12f female × Notch1+/lbd male. The data from Notch1+/12f × Notch112f/lbd crosses were previously published [12] but are 
included for ease of comparison.Ge and Stanley BMC Developmental Biology 2010, 10:36
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null background may function better . In fact, we found
that a significant proportion of Notch112f/tm1Con embryos
survived beyond E12.5 and that some survived to birth.
On the other hand, some compound heterozygous
Notch112f/tm1Con  embryos died at ~E11.5 with similar
defects to Notch112f/lbd. This indicates that Notch112f at a
dose of 50% functions at a threshold of Notch1 signaling
strength that variably sustains embryogenesis through to
birth - a stochastic effect or perhaps a genetic back-
ground effect, since Notch1+/12f and Notch1+/lbd mice were
not extensively backcrossed to C57Bl/6. Nevertheless, the
Notch1 signal strength generated by a single copy of
Notch112f  was intermediate between Notch112f/12f  and
Notch112f/lbd, revealing the importance of maintaining a
certain level of Notch1 signaling for mouse embryogene-
sis to proceed. Fig. 7 summarizes these findings in a dia-
gram which describes a mini-allelic series of available
Notch1 mutants. It includes the Notch1 processing point
mutant Val1744Gly (Notch1v!g/v!g) which has a phenotype
very similar to, but slightly less penetrant than, a Notch1
null [15]. It also includes Notch1+/null heterozygotes that
have mild Notch1 signaling defects uncovered in compe-
tition assays [19] or by close examination of specific cell
types [18,20,21]. Haploinsufficiency of NOTCH1 is the
basis of aortic valve disease in humans [51]. We predict
that  Notch1+/lbd  and  Notch1+/12f  heterozygotes have
slightly less Notch1 signaling than Notch1+/tm1Con  and
should display evidence of more extensive Notch1 signal-
ing defects in particular cell types. The range of Notch1
mutant alleles available in the mouse should be helpful in
identifying new in vivo functions for Notch1.
Methods
Mice
Mice carrying Notch1 lacking the O-fucose site in EGF12
(Notch112f) and mice carrying Notch1 lacking the ligand
binding domain (Notch1lbd) were generated by gene tar-
geting as previously described [8,12]. They were back-
crossed 6-7 generations to C57/Bl6 mice before being
used in these experiments. Notch1l2f/lbd  embryos were
obtained by crossing Notch112f/12f and  Notch1+/lbd mice.
Embryos were collected from E9.5 and yolk sac DNA was
genotyped by PCR using primers 5F: GTATGTATATGG-
GACTTGTAGGCAG and 6R: CTATGAGGGGTCA-
CAGGACCAT, that give a 466 bp product for the
Notch112f allele and a 363 bp product for the wild type
Notch1 allele; and primers 5F and 9R: CTTCATAACCT-
GTGGACGGGAG that give a 575 bp product for the
Notch1lbd  allele. The Notch1  null allele (Notch1tm1Con)
encoding Notch1 lacking the transmembrane domain
[14] backcrossed extensively to C57Bl/6 was kindly pro-
vided by Cynthia Guidos, University of Toronto.
Notch112f/tm1Con  embryos were obtained by crossing
Notch112f/12f and  Notch1+/tm1Con mice and genotyped by
PCR using primers neo-F: CTTGGGTGGAGAGGCT-
ATTC and neo-R: AGGTGAGATGACAGGAGATC for
the Notch1tm1Con allele and primers loxF: GGCGAGCTC-
GAATTGATCC and 9R for Notch112f allele. Mice were
housed under conventional barrier protection in accor-
dance with Einstein and NIH guidelines. Protocols were
approved by the Albert Einstein Animal Institute Com-
mittee.
Embryonic stem cell isolation
ES cells were isolated from E3.5 blastocysts as described
[52], and genomic DNA was genotyped by PCR as
described above. ES cells were routinely cultured on an
S N L 2  γ - i r r a d i a t e d  f e e d e r  l a y e r  [ 5 3 ]  i n  D M E M  s u p p l e -
mented with 15% fetal bovine serum (Gemini, West Sac-
ramento, CA), non-essential amino acids, L-glutamine,
1000 U ESGRO® (Chemicon, Temecula, CA), 1% β-mer-
captoethanol, 25 mM HEPES, penicillin (50 U/ml) and
streptomycin (50 μg/ml). All reagents were from Special-
tyMedia, Lavellette, NJ. Before use in experiments, ES
cells were passaged on gelatinized plates for 2-3 genera-
tions to remove feeder cells.
Western blot analysis
ES cells cultured on gelatinized plates were lysed in RIPA
buffer (Upstate, Lake Placid, NY) containing complete
protease inhibitor cocktail (Roche, Basel, Switzerland) for
30 min on ice and debris was removed by low speed cen-
trifugation. Lysates were resolved by SDS-PAGE, trans-
ferred to polyvinyldifluoride (PVDF) membrane and
probed with 8G10 anti-Notch1 mAb (Upstate, 57-557,
1:500, Lake Placid, NY) for full-length Notch1 or Val1744
Notch1 antibody (Cell Signaling Technology, Val1744,
1:1000, Beverly, MA) for cleaved, activated Notch1, fol-
lowed by horseradish peroxidase(HRP)-conjugated sec-
ondary antibodies. Reactive bands were visualized with
Enhanced Chemiluminescence Reagent (Amersham
Figure 7 An allelic series of Notch1 mutants. Based on data report-
ed herein and from the literature, the relative signaling strength of 
Notch1 mutant alleles in various combinations with wild type or other 
Notch1 mutant alleles is represented as discussed in the Discussion. 
The consequences with respect to time of death of embryos with se-
vere Notch1 signaling defects, or more subtle defects in T cell, CNS or 
cardiac development are noted.Ge and Stanley BMC Developmental Biology 2010, 10:36
http://www.biomedcentral.com/1471-213X/10/36
Page 11 of 13
Pharmacia Biotech, Piscataway, NJ). β-tubulin-III specific
antibody T8660 (Sigma Chemical Co., St. Louis, MO) was
used as a loading control.
Flow cytometry
For cell surface Notch1 expression, 70-80% confluent ES
cells were dissociated from plates using phosphate-buff-
ered saline (PBS)-based enzyme-free dissociation solu-
tion (SpecialtyMedia, Lavellette, NJ) for 10 min at 37°C.
After washing, ES cells (5 × 105) were incubated with 0.5
μg 8G10 anti-Notch1 antibody in Hank's balanced salt
solution containing 3% bovine serum albumin Fraction V
(Sigma Chemical Co., St. Louis, MO), 1 mM CaCl2 and
0.05% Na azide (HBSS/BSA) for 1 h at 4°C, washed and
incubated in Alexa-488 conjugated anti-Hamster IgG
(1:100) in HBSS/BSA in the dark (Invitrogen, Carlsbad,
CA) for 30 min at 4°C. Immunofluorescence was ana-
lyzed on a FACSCalibur flow cytometer (BD Biosciences,
S a n  D i e g o ,  CA ) ,  g a t i n g  o n  l i v e  c e l l s  d e t e r m i n e d  b y  7 -
AAD staining. Data were analyzed using Flowjo software
(Tree Star, San Carlos, CA).
Notch co-culture signaling assay
Notch signaling assays were performed in duplicate as
previously described [54,55]. ES cells were plated at 2 ×
105 cells per well of a six-well plate in ES medium, and co-
transfected the next day with 0.2 μg of TP1-luciferase
Notch reporter plasmid and 0.05 μg of Renilla luciferase
reporter (pRL-TK; Promega, Madison, WI) along with 1.8
μg empty vector alone using FuGene 6 (Roche, Basel,
Switzerland). At 16 h post-transfection, ES cells were
overlaid with 1 × 106  rat Jagged1-expressing L cells
(Jagged1/L), Delta1-expressing L cells (Delta1/L) or
parental L cells [56]. At 48 h after transfection, firefly and
Renilla luciferase activities were quantitated in cell lysates
using a dual luciferase assay (Promega, Madison, WI).
Ligand-dependent Notch activation was expressed as rel-
ative fold-activation of normalized luciferase activity
stimulated by ligand/L cells compared to L cells.
Notch ligand binding assay
Soluble Notch ligand Delta1 with human Fc tag [57,58]
was prepared form HEK-293T cells expressing Delta1-Fc
[17] cultured in α-MEM containing 10% FBS until
70~80% confluence. The medium was changed to 293
SFM II serum-free medium (Invitrogen) and conditioned
medium was collected after 3 days. Cellular debris was
removed by low-speed centrifugation, the supernatant
was filtered and stored at 4°C. Soluble ligand concentra-
tion was determined by western blotting using HRP-con-
jugated anti-human IgG antibody (Jackson
Immunoresearch, West Grove, PA). For the binding assay,
ES cells on plates were dissociated using PBS-based
Enzyme-free dissociation medium for 10 min at 37°C,
and the single cell suspension of ES was incubated with 2
μg/ml Delta1-Fc in HBSS/BSA for 1 h at 4°C, followed by
incubation with 1:100 phycoerythrin (PE)-conjugated
anti-human Fc antibody (Jackson Immunoresearch, West
Grove, PA) for 30 min at 4°C. After washing, live cells
determined by gating on the 7-AAD negative population
were analyzed on a FACS Calibur flow cytometer (BD
Biosciences, San Jose, CA). Ligand binding ability was
measured as mean fluorescence intensity (MFI) using
Flowjo software (Tree Star, San Carlos, CA).
Whole mount immunohistochemistry
Embryos were collected on E9.5 and DNA from yolk sac
was genotyped by PCR. Embryos were fixed in 4% para-
formaldehyde (PFA) in PBS overnight at 4°C, dehydrated
through a methanol series, and bleached in 5% H2O2/
methanol for 5 h. Embryos were rehydrated and placed in
PBSMT (PBS containing 3% nonfat milk, 0.1% Triton X-
100). After 2 h, embryos were incubated with anti-mouse
Pecam1 (1:200; BD Biosciences, San Jose, CA) in PBSMT
overnight at 4°C. After 5 washes with PBSMT embryos
were incubated in a 1:200 dilution of HRP-conjugated
secondary antibody (Zymed, South San Francisco, CA)
overnight. Embryos were washed 5 times in PBSMT and
rinsed in PBT (PBS containing containing 0.2% BSA, 0.1%
Triton X-100), followed developing with DAB kit (Vector
Laboratories, Burlingame, CA). Finally, embryos were
washed in PBT and postfixed in 4% PFA, dehydrated
through a methanol series and cleared in BABB (benzyl
alcohol: benzyl benzoate - 1:2) in a glass Petri dish. Pho-
tos were taken in PBS or BABB using an inverted phase
contrast microscope (Olympus IMT-2, Olympus America
Inc., Center Valley, PA) and a Canon S40 camera with T-
mount adaptor.
Real-Time PCR
Total RNA was extracted from yolk sac or embryo head
using TRIZOL®  reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions. Aliquots of
1 μg RNA were digested by DNase I and cDNA was pre-
pared using RNA PCR Kit ver. 3.0 (Takara Mirus Bio,
Madison, WI) with oligo dT priming. Real-time PCR
reactions with SybrGreen quantification were established
with 1/20 of each cDNA preparation in an Opticon2
DNA Engine (MJ Research, Cambridge, MA). Relative
expression levels after normalization using β-actin were
calculated using the 2-ΔΔCT method ()([59] and confirmed
by the absolute quantification method using standard
curves. Primer pairs for real-time PCR were Ang1 (CAT-
TCTTCGCTGCCATTCTG, GCACATTGCCCATGTT-
GAATC)[60],  Pecam1  (GAGCCCAATC ACGTTTCA
GTTT, TCCTTCCTGCTTCTTGCTA GCT) [60], Vegf
(GGAGATCCTTCGAGGAGCACTT, GCGATTTAG-
CAGCAGATATAAGAA)[60],  Tie2  (ATGTGGAAGTC-Ge and Stanley BMC Developmental Biology 2010, 10:36
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GAGAGGCGAT, CGAATAGCCATCCACTATTG
TCC)[60],  Hey1  (TGAGCTGAGA AGGCTGGTAC,
ACCCCAAACTCCGATAGTCC)[39], Hey2 (TGAGAA-
GACTAGTGCCAACAGC, TGGGC ATCA AAGTAGC-
CTTTA)[39],  Ephrin-B2  (GCGGGATCCAGGA
GATCCCCACTTGGACT, GTGCGCAACCTTCTC-
CTAAG)[39], Hes1 (AAGGCG GA CATTCTGGAAAT,
GTCACCTCGTTCATGCACTC) [61]. Hes5  (TACCT-
GAAACACAGCAAAGC, GCTGGAGTGGTAAG
CAG) [62] and β-actin (GTGGGCCGCTCT
AGGCACCA, TGGCCTT AGGGTT CAGGGGG). All
real-time PCR experiments were performed in duplicate
from ≥ 4 independent samples.
Statistical analysis
Statistical significance was calculated using the unpaired
Student's  t-test (two-tailed) using Graphpad Prism
(GraphPad Software, Inc., San Diego, CA) unless other-
wise noted.
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